Search

Search Constraints

You searched for: Author/Creator Zhou, Cuncai

Search Results

1. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. (July 2021)